Collaborate to accelerate drug discovery
What we do
We develop potential therapeutics through our extensive researcher and foundation networks.
We identify research that can be readily translated to treatments for rare and neglected diseases.
We provide the drug discovery preclinical and clinical expertise to move therapeutics towards the clinic.
We can help you by providing our expertise for your grant submission. For example we recently won an SBIR with PsychoGenics.
To find out more about our capabilities please contact us
How we report on a project
Understand what the customer wants
Understand the problem and not just what our models can do
Clearly describe what we did
What did we find?
How does this benefit the company?
How can we build on this work for the company?
Provide graphical representations of the data
Highlight the advantages and acknowledge limitations
What we have delivered
We have obtained 9 orphan drug designations .
We have delivered measurable results for our collaborators and clients.
We have widely published our results in respected peer reviewed journals.
Client Use Cases
We collaborate with other groups to address complex diseases
For example, we recently announced a new grant to help PsychoGenics design new drugs for mental health disorders.
See some of our collaborations
Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction